Exploring Causal Correlations Between Inflammatory Cytokines and Systemic Lupus Erythematosus: A Mendelian Randomization
Overview
Affiliations
Objectives: Previous studies have reported that a few inflammatory cytokines have associations with systemic lupus erythematosus (SLE)-for example, IL-6, IL-17, and macrophage inflammatory protein (MIP). This Mendelian randomization was conducted to further assess the causal correlations between 41 inflammatory cytokines and SLE.
Methods: The two-sample Mendelian randomization utilized genetic variances of SLE from a large publicly available genome-wide association study (GWAS) (7,219 cases and 15,991 controls of European ancestry) and inflammatory cytokines from a GWAS summary containing 8,293 healthy participants. Causalities of exposures and outcomes were explored mainly using inverse variance weighted method. In addition, multiple sensitivity analyses including MR-Egger, weighted median, simple mode, weighted mode, and MR-PRESSO were simultaneously applied to strengthen the final results.
Results: The results indicated that cutaneous T cell-attracting chemokine (CTACK) and IL-17 may be suggestively associated with the risk of SLE (odds ratio, OR: 1.21, 95%CI: 1.04-1.41, = 0.015; OR: 1.37, 95%CI: 1.03-1.82, = 0.029). In addition, cytokines including beta nerve growth factor, basic fibroblast growth factor, IL-4, IL-6, interferon gamma-induced protein 10, monokine induced by interferon-gamma, MIP1b, stromal cell-derived factor-1 alpha, and tumor necrosis factor-alpha are suggested to be the consequences of SLE disease (Beta: 0.035, = 0.014; Beta: 0.021, = 0.032; Beta: 0.024, = 0.013; Beta: 0.019, = 0.042; Beta: 0.040, = 0.005; Beta: 0.046, = 0.001; Beta: 0.021, = 0.029; Beta: 0.019, = 0.045; Beta: 0.029, = 0.048).
Conclusion: This study suggested that CTACK and IL-17 are probably the factors correlated with SLE etiology, while a couple of inflammatory cytokines are more likely to be involved in SLE development downstream.
Dong K, Mo J, Yan J, Cheng Y, Chen H, Xu N BMC Pregnancy Childbirth. 2025; 25(1):195.
PMID: 39987435 PMC: 11847394. DOI: 10.1186/s12884-025-07318-4.
Chen W, Jing N, Liu Q, Mao H, Wang X, Chen B Medicine (Baltimore). 2025; 104(7):e41466.
PMID: 39960918 PMC: 11835076. DOI: 10.1097/MD.0000000000041466.
Xu S, Li Y, Chen W, Wang K Discov Oncol. 2025; 16(1):92.
PMID: 39869291 PMC: 11772633. DOI: 10.1007/s12672-025-01809-8.
Xu H, Wen Y, Zheng H, Jiang D, Chen W World Allergy Organ J. 2024; 17(12):100993.
PMID: 39650195 PMC: 11621933. DOI: 10.1016/j.waojou.2024.100993.
Song S, Ni J, Sun Y, Pu Q, Zhang L, Yan Q Front Med (Lausanne). 2024; 11:1459752.
PMID: 39574905 PMC: 11580751. DOI: 10.3389/fmed.2024.1459752.